Scientific Advisory Board

David Pompliano

Scientific Advisory Board

Pharmaceutical Industry. Entrepreneur.

Entrepreneur-in-Residence at joined Third Rock. He has over 20 years of experience in the biopharmaceutical industry, most recently as CEO of BioLeap, a discovery stage platform technology company. Before that, he was a senior pharmaceutical executive at GlaxoSmithKline and Merck, where he led drug discovery teams that produced pre-clinical credentials for >30 development candidates and four registered anti-infective (Altabax) and oncology (Tykerb, Votrient, Promacta) drugs.

Pompliano earned the BS and PhD degrees in Chemistry from the University of Virginia and from Stanford University, respectively, and conducted research as a National Institutes of Health Postdoctoral Fellow at Harvard University.  He also is Principal and Owner at Sanderling Consulting LLC and serves on the Scientific Advisory Boards of several biotechnology companies.

Read more

Jordi Vila

Scientific Advisory Board

Infectious Diseases

MD, PhD; Professor of Microbiology, Head of the Department of Clinical Microbiology, Hospital Clínic, School of Medicine, University of Barcelona. Research Professor in the Barcelona Center for International Health Research (CRESIB). +25 years of clinical practice and research in anti-infectives.

Scientific Officer of the European Society of Clinical Microbiology and Infectious Diseases (2002-09) and ECCMID Programme Director (2010-2014). Member of the Programme Committee of the Interscience Conference on Antimicrobial Agents and Chemotherapy, ICAAC (2007-10).

Read more

John Rex

Scientific Advisory Board

Infectious Diseases

VP and Head of Infection, Global Medicines Development, AstraZeneca. 25 years of drug development experience, including 15 years as an academic investigator (National Institutes of Health, Bethesda, Maryland; University of Texas Medical School-Houston).

Since September 2012 Non-Executive Director at F2G Ltd, a UK-based biotechnology company dedicated to the discovery and development of compounds to treat life-threatening systemic fungal infections.

Read more

Jose Vicente Castell

Scientific Advisory Board

Infectious Diseases

PhD, MD, Bs Phar; Professor of Clinical Biochemistry and Immunology at the Faculty of Medicine, University of Valencia. He also reads a postgraduate course on Molecular Toxicology. Director of  the Research Institute of the University Hospital La Fe.

Invited Professor at the Biochemisches Institut der Universität Freiburg  (1987-1988).

International Award of the European Federation of Pharmaceutical Industries (Heidelberg 1990) for the development of cultured human hepatocytes to investigate the hepatotoxic risk of new drugs to man. Expertise fields cover human hepatocytes; drug metabolism and hepatotoxicity and drug-induced allergic hepatitis,  cell therapy with human hepatocytes and PSC-derived hepatocytes.

Has authored 360 papers, including scientific articles published in relevant international journals, book chapters and several reviews.

Read more

Mike Witty

Scientific Advisory Board – Medicinal chemistry / Drug Design

Medicinal Chemistry

PhD; Oxford University. Independent Consultant with 35 years  of experience in drug discovery. Former Vice-President Pfizer Animal Health R&D experienced in a diverse range of therapeutic areas. Now focused on supporting Neglected Tropical Disease R&D.

Consultant for Medicines for Malaria Venture (MMV), University of Cape Town H3D, Global Alliance for Livestock Veterinary Medicines (GALVmed), Wellcome Trust and Bill & Melinda Gates Foundation.

Former Chairman of GALVmed and member of the MMV Expert Scientific Advisory Committee (ESAC), the WHO-TDR Expert Drug Discovery Advisory Committee and the WHO Helminth Drug Initiative.

Read more

Rafael Cantón

Infectious Diseases

PhD, Head of the Clinical Microbiology Department at the University Hospital Ramón y Cajal (Madrid, Spain), investigator at the Ramón y Cajal Institute of Health Research (IRYCIS) and associated Professor of Clinical Microbiology at Complutense University of Madrid, Spain.  Vicepresidente of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), ad hoc member of the Steering Committee of the European Society for Clinical Microbiology and Infectious Disease (ESCMID) and is currently the President of the European Committee for Antimicrobial Susceptibility Testing (EUCAST). He is also associated editor of Clinical Microbiology and Infection journal. He has published more than 300 articles in medical journals and 45 book chapters.

Read more